-
Mashup Score: 6
Most infection events among those with newly diagnosed multiple myeloma in the MajesTEC-7 trial appeared to occur early during study treatment.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
Data support prophylactic treatment with tocilizumab as an option to mitigate the risk of CRS for outpatient dosing of teclistamab.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Prophylactic treatment with tocilizumab shows promise for reducing a serious adverse effect in multiple myeloma treatment.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2MAIC Study Finds Similar Results With Linvoseltamab/Teclistamab in R/R Multiple Myeloma - 22 day(s) ago
Similar outcomes were noted when linvoseltamab and teclistamab were analyzed as treatments for patients with relapsed/refractory multiple myeloma.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2
Belantamab mafodotin in combination with other therapies shows promise for patients with multiple myeloma following the first relapse.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Program Guide – ASCO Meeting Program Guide - 26 day(s) ago
Tiffany Nyamao Mayo Clinic, Rochester, MN Tiffany Nyamao, Rahma M. Warsame, Lisa Hwa, Amie L. Fonder, Miriam A. Hobbs, Tammy McCarty, Sarah Aug, Michelle Burtis, Katharine Dooley, Martha Lacy, Joselle Cook, Angela Dispenzieri Mayo Clinic, Rochester, MN, Division of Hematology, Mayo Clinic, Rochester, MN, Alliance Statistics and Data Management Center and Mayo Clinic Rochester, Rochester, MN Background: Psychological distress and diminished health related quality of life (HRQOL) is associated with
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
@NehaMehtaShahMD @Drjhoffmanmiami 3. e23199 Nyamao: no difference in PROs (PROMIS-29) between reiki vs sham reiki vs no intervention in patients with myeloma. Provocative #mmsm study that highlights how PROs should be used in symptom trials (even if negative). #ASCO24 https://t.co/1rK2ET3Eyr https://t.co/U8oQWQrKc5
-
-
Mashup Score: 26Program Guide – ASCO Meeting Program Guide - 27 day(s) ago
Saurabh Zanwar Division of Hematology, Mayo Clinic, Rochester, MN Saurabh Zanwar, Surbhi Sidana, Leyla Shune, Omar Alexis Castaneda Puglianini, Oren Pasvolsky, Rebecca Gonzalez, Danai Dima, Aimaz Afrough, Gurbakhash Kaur, James A. Davis, Megan Herr, Hamza Hashmi, Peter A. Forsberg, Douglas W. Sborov, Shambavi Richard, Jack Khouri, Yi Lin, Krina K. Patel, Shaji Kumar, Doris K. Hansen Division of Hematology, Mayo Clinic, Rochester, MN, Stanford University Medical Center, Palo Alto, CA, University of Kansas
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 26Program Guide – ASCO Meeting Program Guide - 30 day(s) ago
Saurabh Zanwar Division of Hematology, Mayo Clinic, Rochester, MN Saurabh Zanwar, Surbhi Sidana, Leyla Shune, Omar Alexis Castaneda Puglianini, Oren Pasvolsky, Rebecca Gonzalez, Danai Dima, Aimaz Afrough, Gurbakhash Kaur, James A. Davis, Megan Herr, Hamza Hashmi, Peter A. Forsberg, Douglas W. Sborov, Shambavi Richard, Jack Khouri, Yi Lin, Krina K. Patel, Shaji Kumar, Doris K. Hansen Division of Hematology, Mayo Clinic, Rochester, MN, Stanford University Medical Center, Palo Alto, CA, University of Kansas
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 22Program Guide – ASCO Meeting Program Guide - 1 month(s) ago
Alfred L. Garfall Penn Medicine Abramson Cancer Center, Philadelphia, PA Alfred L. Garfall, Ajay K. Nooka, Niels W.C.J. van de Donk, Philippe Moreau, Manisha Bhutani, Albert Oriol, Thomas G. Martin, Laura Rosiñol, Maria-Victoria Mateos, Nizar J. Bahlis, Rakesh Popat, Britta Besemer, Joaquin Martinez-Lopez, Amrita Y. Krishnan, Michel Delforge, Lin Huang, Deeksha Vishwamitra, Tara Stephenson, Katherine Chastain, Surbhi Sidana Penn Medicine Abramson Cancer Center, Philadelphia, PA, Winship Cancer Institute,
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 26Program Guide – ASCO Meeting Program Guide - 1 month(s) ago
Cesar Rodriguez Valdes Mount Sinai, Division of Hematology/Oncology, Department of Internal Medicine, New York, NY Cesar Rodriguez Valdes, Peter M. Voorhees, Anita D’Souza, Alfred Chung, Sascha Tuchman, Hana Safah, John T. McKay, Katja C Weisel, Raphael Teipel, Neha Korde, Ravi Vij, Orlando Felix Bueno, Tanya Rosenberg, Rajvineeth Kumar Pothacamury, Akshanth Polepally, Aarif Ahsan, Xin (Shane) Li (Lee), Ziyi Jin, Chetasi Talati, Shaji Kumar Mount Sinai, Division of Hematology/Oncology, Department of
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet
Efficacy and manageable safety were observed when combining teclistamab with daratumumab and lenalidomide as treatment in a small cohort of those with newly diagnosed multiple myeloma. #mmsm #ASCO24 | @ASCO https://t.co/JHaIwWX10f